[1]
Gritti, G. et al. 2017. IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?. Mediterranean Journal of Hematology and Infectious Diseases. 9, 1 (Jan. 2017), e2017010. DOI:https://doi.org/10.4084/mjhid.2017.010.